

Lead Product(s) : Bpc-157
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Hospital Ángeles Tijuana
Deal Size : Inapplicable
Deal Type : Inapplicable
PCO-02 - Safety and Pharmacokinetics Trial
Details : Bepecin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 22, 2015
Lead Product(s) : Bpc-157
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Hospital Ángeles Tijuana
Deal Size : Inapplicable
Deal Type : Inapplicable
